News and Announcements
SUDA June 2016 Investor Update; Negotiations to Licence Oro-Muscal Sprays Continue, Expansion of Business Development in China, ChinaBio Conference
- Published June 07, 2016 3:57PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th June 2016, ASX Announcement
SUDA Ltd (ASX: SUD), a leader in oro-muscal drug delivery, notes the weakness in its share price and today provides an update on its activities. Negotiations with pharmaceutical companies to licence SUDA’s first-in-class oro-muscal sprays continue to advance towards final agreements. These discussions span various products and territories. Subject to successful contract negations, SUDA could finalise several agreements in the next few weeks and months.
SUDA has recently expanded its business development outreach in China and met with over 20 Chinese pharmaceutical companies at the ChinaBio conference in Suzhou on 18-19 May 2016. Some of these meetings have already advanced to full due diligence and discussions of terms.
To view the full announcement, please click on the button below.